Sami Capital

Market Drivers● Demographic Tailwinds:Texas’ population over 65 is among the fastest-growing in the country. This group isprojected to nearly double by 2050, with the most rapid growth expected over the next5–10 years. Cardiovascular disease prevalence in Texas remains above national averages,supporting long-term demand for cardiac services. <hr>● Cardiology Industry Trends:U.S. cardiology procedures are expected to grow at an annual rate of 5–8% through 2030,with particular expansion in outpatient diagnostics and interventional cardiology. Cathlab utilization is projected to increase steadily as more procedures shift from hospitals tooutpatient centers.<hr>● Local Market Opportunity:The practice is well-positioned in a large and expanding Texas metro area with room toscale into surrounding communities. A hub-and-spoke model, supported by the existinglab infrastructure and efficient staffing, offers the possibility of adding new locations ingrowth markets.Illustrative Growth ParametersManagement has identified several potential pathways for expansion:● Revenue Growth Potential:With additional sites and expanded lab hours, revenue couldgrow at an estimated 7–9% annually.● EBITDA Preservation: The practice’s margin structure, supported by efficientoperations, could support similar profitability ranges as the business scales.● 10-Year Outlook: Illustrative models show revenue expansion potential from ~$15million today to $28–$38 million over a 10-year horizon, assuming favorable<hr>NEXT STEPSFor a comprehensive financial package, including detailed operational analysis andinvestment terms, interested parties are invited to execute an NDA.<hr>CONTACT📞 <a target="" rel="noopener noreferrer" href="tel:847-606-7950">847-606-7950</a>✉️ <a target="_blank" href="mailto:amit@samicapital.co">amit@samicapital.co</a><hr>Regulatory &amp; Compliance NoticeThis message highlights a potential healthcare practice opportunity. It is not an offer to sell or a solicitation to buy securities.To protect the interests of all parties, we share only limited details at this stage. Completeinformation—including financials and operational insights—will be provided exclusively to qualified buyers after signing a standard Non-Disclosure Agreement (NDA).At <a target="_blank" href="http://SamiCapital.co">SamiCapital.co</a>, we make the M&amp;A process straightforward, confidential, and value-driven.Whether you’re a seller looking to maximize the outcome of your life’s work, or a buyer seeking theright healthcare opportunity, our team ensures a smooth, professional, and rewarding transaction.If you’re ready to explore next steps, let’s connect.

A leading cardiology group in Texas, operating a private cardiac lab with efficient staffing and
established referral networks. The owner, a younger physician, is open to remaining active with the business for 2–4 years to support growth and transition.

Revenue of $14–$17 million with EBITDA in the range of $5–$7 million -Leading Cardiology Group

Amit Garg

Course Details

Virtual Family Office Services for Physicians & Entrepreneurs

(847) 606-7950

[email protected]

Copyright © 2025, all rights reserved. SamiCapital.co